Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Schrodinger, Inc. - Common Stock (NQ:SDGR)

22.52 +0.56 (+2.55%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Schrodinger, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries
Evogene employs an artificial intelligence platform for decoding plant phenotypes and microbial genomes. Consider its' research agenda, applications, and at-the-market products. The set-up may present... 
Via Talk Markets
Schrödinger Publishes Inaugural Corporate Sustainability Report
From Schrödinger, Inc.
Via Business Wire
Schrödinger to Announce First Quarter 2023 Financial Results on May 4
From Schrödinger
Via Business Wire
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Analyst Expectations for Schrodinger's Future
 
Via Benzinga
The C3.ai Stock Debate: Overpriced or Underestimated?
The valuation of AI stock was attractive many months ago, but at this point their price-sales ratio has become quite elevated. 
Via InvestorPlace
3 Industries Set to Be Transformed by the AI Revolution
AI will allow companies in many sectors to save a great deal of money and tremendously increase their revenue. 
Via InvestorPlace
The 3 Best AI Stocks to Buy Right Now
Here are the best AI stocks to buy now as companies look to harness the power of this disruptive technology. 
Via InvestorPlace
3 Tech Stocks to Buy for the Fourth Industrial Revolution
These companies all utilize multiple technologies that are part of the Fourth Industrial Revolution, making them great tech stocks to buy. 
Via InvestorPlace
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Why Shares of Schrödinger Were Up Today
The company delivered a nice earnings surprise. 
Via The Motley Fool
Citigroup Maintains Buy Rating for Schrodinger: Here's What You Need To Know
 
Via Benzinga
Evogene Offers An Excellent Risk/Reward Ratio
We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine. Investors only need one of the company's subsidiaries to succeed, to de-risk their... 
Via Talk Markets
Not Quite a Bailout: So Much Banking News to Discuss
Plus, two Motley Fool analysts share their insight on a pair of stocks to watch. 
Via The Motley Fool
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
Via InvestorPlace
MarketBeat Week in Review – 3/6 - 3/10
Stocks are down sharply to end the week, and the MarketBeat staff continues to show investors why dividend stocks need to be part of your playbook 
Via MarketBeat
Topics Artificial Intelligence Economy
4 Analysts Have This to Say About Schrodinger
 
Via Benzinga
3 Amazing AI Stocks for Your March Buy List
With the Street catching onto the transformational power of AI, these amazing AI stocks are very well-positioned to climb tremendously. 
Via InvestorPlace
Schrodinger is an AI-Powered Drug Discovery Developer to Watch
Drug discovery software developer Schrodinger Inc. (NASDAQ: SDGR) stock has been trying to recover after plummeting over 80% off its all-time high of $117 
Via MarketBeat
Topics Artificial Intelligence
3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
Schrödinger Reports Strong Fourth Quarter and Full-Year 2022 Financial Results
From Schrödinger, Inc.
Via Business Wire
Earnings Scheduled For February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter. 
Via Benzinga
3 AI Stocks to Buy for the Future of Automation
Increased appreciation for AI and the Street's reduced hostility to growth stocks make this a good time to find AI stocks to buy. 
Via InvestorPlace
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Schrödinger, Inc.
Via Business Wire
Schrödinger Receives $111.3 Million Distribution from Sale of Nimbus’s TYK2 Inhibitor to Takeda
From Schrödinger Inc.
Via Business Wire
Schrödinger to Announce Fourth Quarter and Full-Year 2022 Financial Results on February 28
From Schrödinger
Via Business Wire
Week In Review: Structure Stages $161 Million US IPO For AI/Structure-Based Drug Development
Structure Therapeutics raised $161 million in a successful US IPO to support development of its oral therapeutics portfolio aimed at chronic metabolic and pulmonary diseases. Schrödinger is a... 
Via Talk Markets
Schrödinger to Present at SVB Securities Global Biopharma Conference
From Schrödinger
Via Business Wire
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.